RxDoctor Payments Data

Annie Cherian

Psychiatry · Pensacola, FLNPI 1578547246

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.8% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Johnson & Johnson at 24.3% of the total. Reporting peaked in 2019 at $1,963 and has fallen 99.0% since, to $19 in 2023.

$3,187in general payments, 2019–2025

Across 191 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$775
  • Otsuka America Pharmaceutical, Inc.$708
  • Sunovion Pharmaceuticals Inc.$657
  • Alkermes, Inc.$328
  • Teva Pharmaceuticals USA, Inc.$197
  • Neurocrine Biosciences, Inc.$197
  • plus $324 from 8 others

What the payments were for

  • Food & beverage$2,99094%
  • Education$1976%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,187 in reported general payments places this provider in the 75th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Other psychiatry in Pensacola

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →